AI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read More
Abstracts for oral and poster presentations will represent the core of the scientific program at this meeting. Abstracts pertaining to human atopic dermatitis and related fields including animal models are appropriate. Check out your submissions Is your abstract accepted? Please check: …and what to do now? Please sign-in to the Platform and head to the […]
Read More
A One Health Lens on Atopic Dermatitis: Integrating Wastewater Data into a Comprehensive Digital Framework—Is There a Role for Zoonotic Streptococci in AD Flares? The publication by Oh et al. in Water Research (2025) [DOI: 10.1016/j.watres.2025.124012] marks a transformative contribution to environmental dermatology, offering a predictive surveillance model for atopic dermatitis (AD) that is deeply rooted […]
Read MoreAI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read More
We are most saddened by the loss of our esteemed colleague Dr Robert SIDBURY in Chicago this month. Dr SIDBURY was professor in pediatrics and dermatology at the University of Washington School of Medicine, division chief of dermatology at Seattle Children’s Hospital, a co-chair of the recent American Academy of Dermatology Atopic Dermatitis Guidelines, Councillor […]
Read More
Reclaiming Treatment Success in Atopic Dermatitis:Patients Matter Most In the evolving landscape of atopic dermatitis (AD) therapeutics, we are witnessing a striking paradox: never have so many therapies been available, yet patient dissatisfaction remains high. Why? Because the metrics guiding clinical trials and regulatory approvals often diverge sharply from what patients truly value. A rigid […]
Read MoreAI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read More
The ISAD supports GADA’s initiative to collect global epidemiological data using appropriate instruments, which are not always readily available. This real-world data initiative should be encouraged, particularly given the significant information gaps in countries and regions with limited medical infrastructure. If you are interested in participating, please visit https://qualtrics.kcl.ac.uk/ On behalf of the Global Atopic […]
Read More
Different faces, shared targets: the curious convergence of AD, AA, and vitiligo In the evolving landscape of dermatology and clinical immunology, a compelling paradox is emerging: three phenotypically distinct conditions—atopic dermatitis (AD), alopecia areata (AA), and vitiligo—are increasingly found to share overlapping immunological features and respond to similar targeted therapies. Historically, the connections among these […]
Read MoreAD hidden hematologic risk: clonal hematopoiesis of indeterminate potential (CHIP) + An unusual facial bump related to AD + Switching off selectively skin lipid synthesis: a reversible human model of ceramide depletion + Beyond the skin: suicidal risk is real in AD + Complement, an overlooked driver of Th2 Immunity in AD
Read More